Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2011 (2011), Article ID 125271, 7 pages
http://dx.doi.org/10.4061/2011/125271
Clinical Study

The Possible Clinical Predictors of Fatigue in Parkinson’s Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project

1National Parkinson Foundation Centre of Excellence, King’s College Hospital, King’s College London, Denmark Hill Campus, 9th Floor, Ruskin Wing, London SE5 9RS, UK
2University Hospital Lewisham, London SE13 6LH, UK
3University of Surrey, Surrey GU2 7XH, UK
4Alzheimer Disease Research Unit, CIEN Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Madrid, Spain
5Department of Neurology, University Hospital, Lund University, Lund, Sweden
6Department of Neurology, Central Hospital, Reinkenheide, Bremerhaven, Germany
7Department of Neurological Sciences, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy
8Department of Neurology, IRCCS San Raffaele, 00163 Rome, Italy
9Department of Neurology, IRCCS San Camillo Venice and University of Padua, 35122 Padua, Italy

Received 23 December 2010; Revised 14 September 2011; Accepted 14 September 2011

Academic Editor: Antonio Strafella

Copyright © 2011 Vinod Metta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. R. Chaudhuri, D. G. Healy, and A. H. Schapira, “Non-motor symptoms of Parkinson's disease: diagnosis and management,” Lancet Neurology, vol. 5, no. 3, pp. 235–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. K. R. Chaudhuri and Y. Naidu, “Early Parkinson's disease and non-motor issues,” Journal of Neurology, vol. 255, supplement 5, pp. 33–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Martinez-Martin, C. Rodriguez-Blazquez, K. Abe et al., “International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease,” Neurology, vol. 73, no. 19, pp. 1584–1591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. R. Chaudhuri, C. Prieto-Jurcynska, Y. Naidu et al., “The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire,” Movement Disorders, vol. 25, no. 6, pp. 704–709, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Alves, T. Wentzel-Larsen, and J. P. Larsen, “Is fatigue an independent and persistent symptom in patients with Parkinson disease?” Neurology, vol. 63, no. 10, pp. 1908–1911, 2004. View at Google Scholar · View at Scopus
  6. J. H. Friedman and H. Friedman, “Fatigue in Parkinson's disease: a nine-year follow-up,” Movement Disorders, vol. 16, no. 6, pp. 1120–1122, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. J. van Hilten, M. Weggeman, E. A. van der Velde, G. A. Kerkhof, J. G. Van Dijk, and R. A. C. Roos, “Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease,” Journal of Neural Transmission, vol. 5, no. 3, pp. 235–244, 1993. View at Google Scholar · View at Scopus
  8. E. Havlikova, J. Rosenberger, I. Nagyova et al., “Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease,” Parkinsonism and Related Disorders, vol. 14, no. 3, pp. 187–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Havlikova, J. Rosenberger, I. Nagyova et al., “Impact of fatigue on quality of life in patients with Parkinson's disease,” European Journal of Neurology, vol. 15, no. 5, pp. 475–480, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Herlofson and J. P. Larsen, “The influence of fatigue on health-related quality of life in patients with Parkinson's disease,” Acta Neurologica Scandinavica, vol. 107, no. 1, pp. 1–6, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Barone, A. Antonini, C. Colosimo et al., “The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease,” Movement Disorders, vol. 24, no. 11, pp. 1641–1649, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. van Hilten, G. Hoogland, E. A. van der Velde, H. A. M. Middelkoop, G. A. Kerkhof, and R. A. C. Roos, “Diurnal effects of motor activity and fatigue in Parkinson's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 56, no. 8, pp. 874–877, 1993. View at Google Scholar · View at Scopus
  13. J. Friedman and H. Friedman, “Fatigue in Parkinson's disease,” Neurology, vol. 43, no. 10, pp. 2016–2018, 1993. View at Google Scholar · View at Scopus
  14. L. M. Shulman, R. L. Taback, A. A. Rabinstein, and W. J. Weiner, “Non-recognition of depression and other non-motor symptoms in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 8, no. 3, pp. 193–197, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Abe, M. Takanashi, and T. Yanagihara, “Fatigue in patients with Parkinson's disease,” Behavioural Neurology, vol. 12, no. 3, pp. 103–106, 2000. View at Google Scholar · View at Scopus
  16. K. Karlsen, J. P. Larsen, E. Tandberg, and K. Jørgensen, “Fatigue in patients with Parkinson's disease,” Movement Disorders, vol. 14, no. 2, pp. 237–241, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. J. S. Lou, G. Kearns, B. Oken, G. Sexton, and J. Nutt, “Exacerbated physical fatigue and mental fatigue in Parkinson's disease,” Movement Disorders, vol. 16, no. 2, pp. 190–196, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. K. R. Chaudhuri, P. Martinez-Martin, R. G. Brown et al., “The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study,” Movement Disorders, vol. 22, no. 13, pp. 1901–1911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. R. Chaudhuri, P. Martinez-Martin, A. H. V. Schapira et al., “International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study,” Movement Disorders, vol. 21, no. 7, pp. 916–923, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. K. R. Chaudhuri, L. Yates, and P. Martinez-Martin, “The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential,” Current Neurology and Neuroscience Reports, vol. 5, no. 4, pp. 275–283, 2005. View at Google Scholar · View at Scopus
  21. J. S. Lou, G. Kearns, T. Benice, B. Oken, G. Sexton, and J. Nutt, “Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo controlled, crossover study,” Movement Disorders, vol. 18, no. 10, pp. 1108–1114, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Schifitto, J. H. Friedman, D. Oakes et al., “Fatigue in levodopa-naïve subjects with Parkinson disease,” Neurology, vol. 71, no. 7, pp. 481–485, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. A. Mendonça, K. Menezes, and M. S. Jog, “Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial,” Movement Disorders, vol. 22, no. 14, pp. 2070–2076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. G. Laforge, J. S. Rossi, J. O. Prochaska, W. F. Velicer, D. A. Levesque, and C. A. McHorney, “Stage of regular exercise and health-related quality of life,” Preventive Medicine, vol. 28, no. 4, pp. 349–360, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Vuillemin, S. Boini, S. Bertrais et al., “Leisure time physical activity and health-related quality of life,” Preventive Medicine, vol. 41, no. 2, pp. 562–569, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. G. C. Wendel-Vos, A. J. Schuit, M. A. R. Tijhuis, and D. Kromhout, “Leisure time physical activity and health-related quality of life: cross-sectional and longitudinal associations,” Quality of Life Research, vol. 13, no. 3, pp. 667–677, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. C. E. Garber and J. H. Friedman, “Effects of fatigue on physical activity and function in patients with Parkinson's disease,” Neurology, vol. 60, no. 7, pp. 1119–1124, 2003. View at Google Scholar
  28. N. P. Poulton and G. D. Muir, “Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-Parkinsonian rats,” Experimental Neurology, vol. 193, no. 1, pp. 181–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. D. Cohen, J. L. Tillerson, A. D. Smith, T. Schallert, and M. J. Zigmond, “Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF,” Journal of Neurochemistry, vol. 85, no. 2, pp. 299–305, 2003. View at Google Scholar · View at Scopus
  30. A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 3, pp. 181–184, 1992. View at Google Scholar · View at Scopus
  31. S. Fahn, R. L. Elton, and Members of the UPDRS Development Committee, “Unified Parkinson’s disease Rating Scale,” in Recent Developments in Parkinson’s Disease, S. Fahn et al., Ed., pp. 153–164, Macmillan Healthcare Information, Florham Park, NJ, USA, 1987. View at Google Scholar
  32. B. S. Linn, M. W. Linn, and L. Gurel, “Cumulative illness rating scale,” Journal of the American Geriatrics Society, vol. 16, no. 5, pp. 622–626, 1968. View at Google Scholar · View at Scopus
  33. M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression and mortality,” Neurology, vol. 17, no. 5, pp. 427–442, 1967. View at Google Scholar · View at Scopus
  34. B. Dubois, A. Slachevsky, I. Litvan, and B. Pillon, “The FAB: a frontal assessment battery at bedside,” Neurology, vol. 55, no. 11, pp. 1621–1626, 2000. View at Google Scholar · View at Scopus
  35. C. Jenkinson, R. Fitzpatrick, V. Peto, R. Greenhall, and N. Hyman, “The Parkinson's disease questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score,” Age and Ageing, vol. 26, no. 5, pp. 353–357, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Martínez-Martín, J. Benito-León, F. Alonso et al., “Quality of life of caregivers in Parkinson's disease,” Quality of Life Research, vol. 14, no. 2, pp. 463–472, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. A. S. Zigmond and R. P. Snaith, “The hospital anxiety and depression scale,” Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361–370, 1983. View at Google Scholar · View at Scopus
  38. K. Abe, M. Takanashi, T. Yanagihara, and S. Sakoda, “Pergolide mesilate may improve fatigue in patients with Parkinson's disease,” Behavioural Neurology, vol. 13, no. 3-4, pp. 117–121, 2001. View at Google Scholar · View at Scopus
  39. L. M. Shulman, R. L. Taback, J. Bean, and W. J. Weiner, “Comorbity of the nonmotor symptoms of Parkinson's disease,” Movement Disorders, vol. 16, no. 3, pp. 507–510, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Pavese, V. Metta, S. K. Bose, K. R. Chaudhuri, and D. J. Brooks, “Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction,” Brain, vol. 133, no. 11, pp. 3434–3443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. M. Stahl, L. Zhang, C. Damatarca, and M. Grady, “Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder,” Journal of Clinical Psychiatry, vol. 64, supplement 14, pp. 6–17, 2003. View at Google Scholar · View at Scopus
  42. A. Tylee, M. Gastpar, J.-P. Lépine, and J. Mendlewicz, “DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee,” International Clinical Psychopharmacology, vol. 14, no. 3, pp. 139–151, 1999. View at Google Scholar
  43. W. C. Drevets, M. E. Thase, E. L. Moses-Kolko et al., “Serotonin-1A receptor imaging in recurrent depression: replication and literature review,” Nuclear Medicine and Biology, vol. 34, no. 7, pp. 865–877, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. P. A. Sargent, K. Husted Kjaer, C. J. Bench et al., “Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment,” Archives of General Psychiatry, vol. 57, no. 2, pp. 174–180, 2000. View at Google Scholar · View at Scopus
  45. J. Andersen, E. Aabro, and N. Gulmann, “Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA,” Acta Neurologica Scandinavica, vol. 62, no. 4, pp. 210–219, 1980. View at Google Scholar · View at Scopus